The DOI matches its Crossref record; 142 of the 143 references it cites were found in a registry or an index.
Mechanisms Governing Metastatic Dormancy and Reactivation
Open accessAbstract
Many cancer patients suffer from metastatic relapse several years after they have undergone radical surgery. Early cancer cell dissemination followed by a protracted period of dormancy potentially explains this prevalent clinical behavior. Increasing evidence suggests that the metastasis-initiating cells are cancer stem cells or revert to this functional state upon infiltrating a target organ. Their entry into dormancy and subsequent reactivation are governed by intrinsic programs and by contextual cues, which resemble those regulating the self-renewal capability of adult stem cells. In addition, metastatic cells undergoing reactivation are nursed by specialized extracellular matrix niches, which support positive signals, such as Wnt and Notch, and attenuate negative signals, such as BMP. In spite of significant remaining uncertainties, these findings provide a framework to understand the logic of metastatic dormancy and reactivation and open new avenues for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The analogy between senescence and dormancy in some tumours also implies that the in vivo senescence-like arrest may be unstable, because dormant tumour cells can regrow after long periods of time 130,140”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [140]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M. W., Reinhard, F., Zhang, C. C., Shipitsin, M. V., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,839
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
A Perspective on Cancer Cell Metastasis
Chaffer, C. L., & Weinberg, R. A. (2011) · Science · doi:10.1126/science.1203543 · Cited by 4,905
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Cited by
Sorted by citations
Items 201–300 of 587
Adaptive Fibrogenic Reprogramming of Osteosarcoma Stem Cells Promotes Metastatic Growth
Zhang, W., Zhao, J.-M., Lin, J., Hu, C.-Z., Zhang, J., YANG, W.-L., Zhang, J., Zhang, J., & Zhu, J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.103 · Cited by 40
Immunogenic, cellular, and angiogenic drivers of tumor dormancy‐a melanoma view
Senft, D., & Ronai, Z. A. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12432 · Cited by 44
3D functional and perfusable microvascular networks for organotypic microfluidic models
Bersini, S., & Moretti, M. (2015) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-015-5520-5 · Cited by 39
Quiles, J. L., Sánchez‐González, C., Ramírez, L. V., Giampieri, F., Navarro‐Hortal, M. D., Xiao, J., Llopis, J., Battino, M. A., & Varela‐López, A. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8051 · Cited by 39
Molecular pathology underlying the robustness of cancer stem cells
Yoshida, G. J., & Saya, H. (2021) · Regenerative Therapy · doi:10.1016/j.reth.2021.02.002 · Cited by 38
Emerging Role of NRF2 Signaling in Cancer Stem Cell Phenotype
Hallis, S. P., Kim, J. M., & Kwak, M. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.2196 · Cited by 39
Ji, X., Bei, H., Zhong, G., Shao, H., He, X., Qian, X., Zhang, Y., & Zhao, X. (2023) · Small · doi:10.1002/smll.202207606 · Cited by 39
Wise, R., Duhachek-Muggy, S., Qi, Y., Žółkiewski, M., & Żółkiewska, A. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3820-1 · Cited by 38
Spontaneous Fusion of MSC with Breast Cancer Cells Can Generate Tumor Dormancy
Melzer, C., von der Ohe, J., Luo, T., & Hass, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115930 · Cited by 37
Dai, Y., Wang, L., Tang, J., Cao, P., Luo, Z., Sun, J., Kiflu, A. B., Sai, B., Zhang, M., Wang, F., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8172 · Cited by 36
Research Progress of Plant-Derived Natural Products against Drug-Resistant Cancer
Liu, W., Wang, Y., Xia, L., & Li, J. (2024) · Nutrients · doi:10.3390/nu16060797 · Cited by 38
The Role of Complement in Angiogenesis
Markiewski, M. M., Daugherity, E. A., Reese, B., & Karbowniczek, M. (2020) · Antibodies · doi:10.3390/antib9040067 · Cited by 40
Chowdhury, R., Ganeshan, B., Irshad, S., Lawler, K., Eisenblätter, M., Milewicz, H., Rodriguez‐Justo, M., Miles, K. A., Ellis, P., Groves, A. M., et al. (2014) · BJR|case reports · doi:10.1259/bjr.20140065 · Cited by 34
Cancer stem cells: Signaling pathways and therapeutic targeting
Talukdar, J., Srivastava, T. P., Sahoo, O. S., Karmakar, A., Rai, A. K., Sarma, A., Gogoi, G., Alqahtani, M. S., Abbas, M. A. E., Dhar, R., et al. (2023) · MedComm – Oncology · doi:10.1002/mog2.62 · Cited by 35
Cifuentes, F., VALENZUELA, R. H., Contreras, H. R., & Castellón, E. A. (2015) · Oncology Reports · doi:10.3892/or.2015.4319 · Cited by 34
New approaches to targeting the bone marrow microenvironment in multiple myeloma
Gooding, S., & Edwards, C. M. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.02.013 · Cited by 35
Wnt Signaling in the Development of Bone Metastasis
Ben-Ghedalia-Peled, N., & Vago, R. (2022) · Cells · doi:10.3390/cells11233934 · Cited by 33
Farino, C. J., Pradhan, S., & Slater, J. H. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002227 · Cited by 34
Cancer progression as a learning process
Shomar, A., Barak, O., & Brenner, N. (2022) · iScience · doi:10.1016/j.isci.2022.103924 · Cited by 33
Dong, L., & Neužil, J. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394625-6.00008-8 · Cited by 34
Touil, Y. S., Ségard, P., Ostyn, P., Bégard, S., Aspord, C., Machhour, R. E., Masselot, B., Vandomme, J., Flamenco, P., Idziorek, T., et al. (2016) · Scientific Reports · doi:10.1038/srep30405 · Cited by 32
Yang, X. H., Tang, F., Shin, J., & Cunningham, J. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-00122-x · Cited by 32
Ramírez, L. V. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.027 · Cited by 35
The Cell Biology of Metastatic Invasion in Pancreatic Cancer: Updates and Mechanistic Insights
Joshi, V. B., Gutierrez Ruiz, O. L., & Razidlo, G. L. (2023) · Cancers · doi:10.3390/cancers15072169 · Cited by 32
Protracted dormancy of pre-leukemic stem cells
Ford, A. M., Mansur, M. B., Furness, C. L., van Delft, F. W., Okamura, J., Suzuki, T., Kobayashi, H., Kaneko, Y., & Greaves, M. F. (2015) · Leukemia · doi:10.1038/leu.2015.132 · Cited by 32
Chemoquiescence for Ideal Cancer Treatment and Prevention: Where Are We Now?
Kangwan, N., Park, J., Kim, E., & Hahm, K. B. (2014) · Journal of Cancer Prevention · doi:10.15430/jcp.2014.19.2.89 · Cited by 31
The role of hematopoietic stem cell niche in prostate cancer bone metastasis
Decker, A. M., Jung, Y., Cackowski, F. C., & Taichman, R. S. (2016) · Journal of bone oncology · doi:10.1016/j.jbo.2016.02.005 · Cited by 31
Hydroxyethyl starch stabilized copper-diethyldithiocarbamate nanocrystals for cancer therapy
Xiao, C., Li, J., Wang, X., Li, S., Xu, C., Zhang, Z., Hua, A., Ding, Z., Zhang, B., Yang, X., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.02.043 · Cited by 33
Nakamura, T., Shinriki, S., Jono, H., Guo, J., Ueda, M., Hayashi, M., Yamashita, S., Zijlstra, A., Nakayama, H., Hiraki, A., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2826 · Cited by 31
DNA polymerase iota (Pol ι) promotes invasion and metastasis of esophageal squamous cell carcinoma
Zou, S., Shang, Z., Liu, B., Zhang, S., Wu, J., Huang, M., Ding, W., & Zhou, J. (2016) · Oncotarget · doi:10.18632/oncotarget.8580 · Cited by 31
Ras and Wnt Interaction Contribute in Prostate Cancer Bone Metastasis
Lin, S., Mokgautsi, N., & Liu, Y. (2020) · Molecules · doi:10.3390/molecules25102380 · Cited by 31
The role of host environment in cancer evolution
Solary, É., & Laplane, L. (2020) · Evolutionary Applications · doi:10.1111/eva.13039 · Cited by 33
Safa, A. R. (2020) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2020.55 · Cited by 32
The biology and clinical implications of prostate cancer dormancy and metastasis
Morrissey, C. M., Vessella, R. L., Lange, P. H., & Lam, H. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1353-4 · Cited by 29
Epigenetic plasticity in metastatic dormancy: mechanisms and therapeutic implications
Robinson, N. J., Parker, K. A., & Schiemann, W. P. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.177 · Cited by 31
Trends in Bone Metastasis Modeling
Laranga, R., Duchi, S., Ibrahim, T., Guerrieri, A. N., Donati, D. M., & Lucarelli, E. (2020) · Cancers · doi:10.3390/cancers12082315 · Cited by 31
Calle, A. S., Yamamoto, T., Kawamura, Y., Hironaka‐Mitsuhashi, A., Ono, M., Tsuda, H., Shimomura, A., Tamura, K., Takeshita, F., Ochiya, T., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12704 · Cited by 28
Serum Amyloid A Proteins and Their Impact on Metastasis and Immune Biology in Cancer
Lee, J., & Beatty, G. L. (2021) · Cancers · doi:10.3390/cancers13133179 · Cited by 28
Hasan, H., Sohal, I., Soto-Vargas, Z., Byappanahalli, A. M., Humphrey, S. E., Kubo, H., Kitdumrongthum, S., Copeland, S. E., Tian, F., Chairoungdua, A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-04940-6 · Cited by 29
Role of myeloid-derived suppressor cells in tumor recurrence
Cole, K., Al-Kadhimi, Z. S., & Talmadge, J. E. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10079-1 · Cited by 30
Means to the ends: The role of telomeres and telomere processing machinery in metastasis
Robinson, N. J., & Schiemann, W. P. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.10.005 · Cited by 28
Millar, M. W., Corson, N., & Xu, L. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00008 · Cited by 28
Yu, Z., Ma, J., Li, X., Liu, Y., Li, M., Wang, L., Zhao, M., He, H., Zhang, Y., Rao, Q., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28369-y · Cited by 27
Molecular principles of tissue invasion and metastasis
Dhanisha, S. S., & Guruvayoorappan, C. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00348.2022 · Cited by 29
FRIZZLED7 Is Required for Tumor Inititation and Metastatic Growth of Melanoma Cells
Tiwary, S., & Xu, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147638 · Cited by 26
Nicolini, A., Rossi, G., Ferrari, P., & Carpi, A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.03.009 · Cited by 26
Lipid-Based Nano-Sized Cargos as a Promising Strategy in Bone Complications: A Review
Hallan, S. S., Amirian, J., Brangule, A., & Bandere, D. (2022) · Nanomaterials · doi:10.3390/nano12071146 · Cited by 27
Immune surveillance of brain metastatic cancer cells is mediated by IFITM1
She, X., Shen, S., Chen, G., Gao, Y., Ma, J., Gao, Y., Liu, Y., Gao, G., Zhao, Y. F., Wang, C., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2022111112 · Cited by 24
Iron metabolism: backfire of cancer cell stemness and therapeutic modalities
Yu, R., Hang, Y., Tsai, H., Wang, D., & Zhu, H. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03329-x · Cited by 29
Wu, F., Mu, L., Li, X.-L., Hu, Y., Liu, H., Han, L., & Gong, J. (2017) · Oncotarget · doi:10.18632/oncotarget.19638 · Cited by 25
Jiang, Y., Guo, Y., Hao, J., Guenter, R. E., Lathia, J. D., Beck, A. W., Hattaway, R., Hurst, D. R., Wang, Q. J., Liu, Y., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02308-6 · Cited by 25
Chromatin accessibility regulates chemotherapy-induced dormancy and reactivation
Wang, L., Qiu, P., Yin, N., Xie, Y., Xu, J., Chen, A., Yi, J., Tang, J., & Xiang, J. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.07.019 · Cited by 25
Lee, K., Chen, G., Chen, T., Kuo, Y., & Su, Y.-K. (2020) · Cancers · doi:10.3390/cancers12082122 · Cited by 25
Awakening of Dormant Breast Cancer Cells in the Bone Marrow
Wieder, R. (2023) · Cancers · doi:10.3390/cancers15113021 · Cited by 26
Baldassarri, I., Tavakol, D. N., Graney, P. L., Chramiec, A. G., Hibshoosh, H. H., & Vunjak‐Novakovic, G. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2405257121 · Cited by 25
Inhibition of DEC2 is necessary for exiting cell dormancy in salivary adenoid cystic carcinoma
Yang, X. Y., Wu, J., Li, M., Zhang, W., Gao, X., Wang, H., Yu, X., Pang, X., Zhang, M., Liang, X., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01956-0 · Cited by 23
Mokhtari, R. B., Sambi, M., Qorri, B., Baluch, N., Ashayeri, N., Kumar, S., Cheng, H. M., Yeger, H., Das, B., & Szewczuk, M. R. (2021) · Cancers · doi:10.3390/cancers13143596 · Cited by 25
Angiopoietin-2 promotes ER+ breast cancer cell survival in bone marrow niche
Han, H. H., Kim, B. G., Lee, J. H., Kang, S., Kim, J. E., & Cho, N. H. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0086 · Cited by 24
Lange, T., Oh‐Hohenhorst, S. J., Joosse, S. A., Pantel, K., Hahn, O., Gosau, T., Dyshlovoy, S. A., Wellbrock, J., Feldhaus, S., Maar, H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35695-8 · Cited by 25
The concepts of rechallenge and retreatment in melanoma: A proposal for consensus definitions
Gebhardt, C., Ascierto, P. A., Atkinson, V. G., Corrie, P. G., Dummer, R., & Schadendorf, D. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.07.016 · Cited by 25
Clinical applications of circulating tumor cells in metastasis and therapy
Yang, C., Liu, C., Xia, C., & Fu, L. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01733-y · Cited by 27
Rescue of Targeted Nonstem-Like Cells from Bystander Stem-Like Cells in Human Fibrosarcoma HT1080
Liu, Y., Kobayashi, A., Fu, Q., Yang, G., Konishi, T., Uchihori, Y., Hei, T. K., & Wang, Y. (2015) · Radiation Research · doi:10.1667/rr14050.1 · Cited by 23
Prostate Cancer Dormancy and Reactivation in Bone Marrow
Singh, D. K., Patel, V. G., Oh, W. K., & Aguirre‐Ghiso, J. A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122648 · Cited by 27
Murakami, K., Umemura, N., Adachi, M., Motoki, M., & Ohkoshi, E. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11658 · Cited by 23
Gu, W., Prasadam, I., Yu, M., Zhang, F., Ling, P., Xiao, Y., & Yu, C. (2015) · BMC Cancer · doi:10.1186/s12885-015-1614-1 · Cited by 23
Cytokeratin 19 expression in primary thoracic tumors and lymph node metastases
Masai, K., Nakagawa, K., Yoshida, A., Sakurai, H., WATANABE, S.-I. J., Asamura, H., & Tsuta, K. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.09.018 · Cited by 23
Suppression of Breast Cancer Metastasis Using Stapled Peptides Targeting the WASF Regulatory Complex
Cowell, J. K., Teng, Y., Bendzunas, N. G., Ara, R., Arbab, A. S., & Kennedy, E. J. (2017) · Cancer Growth and Metastasis · doi:10.1177/1179064417713197 · Cited by 24
Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence
Kottke, T., Evgin, L., Shim, K. G., Rommelfanger, D. M., Boisgerault, N., Zaidi, S., Díaz, R. M., Thompson, J., Ilett, E. J., Coffey, M. C., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0175 · Cited by 24
Zhang, G.-J., Zhao, J., Jiang, M.-L., & Zhang, L.-C. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.045 · Cited by 23
Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design
Kejík, Z., Kaplánek, R., Dytrych, P., Masařík, M., Veselá, K., Abramenko, N., Hoskovec, D., Vašáková, M., Králová, J., Pavel Martasek, E., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111879 · Cited by 23
Matricellular proteins: multifaceted extracellular regulators in tumor dormancy
Wu, T., & Ouyang, G. (2014) · Protein & Cell · doi:10.1007/s13238-014-0023-6 · Cited by 23
Tao, F., Ruan, S., Liu, W., Wang, L., Xiong, Y., & Shen, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168892 · Cited by 23
A Perspective on Therapeutic Pan-Resistance in Metastatic Cancer
Korentzelos, D. K., Clark, A. M., & Wells, A. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197304 · Cited by 21
Premalignant pancreatic cells seed stealth metastasis in distant organs in mice
Yamaguchi, J., Kokuryo, T., Yokoyama, Y., Ebata, T., Ochiai, Y., & Nagino, M. (2021) · Oncogene · doi:10.1038/s41388-021-01706-8 · Cited by 22
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma
Golinelli, G., Grisendi, G., Dall’Ora, M., Casari, G., Spano, C., Talami, R., Banchelli, F., Prapa, M., Chiavelli, C., Rossignoli, F., et al. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101240 · Cited by 22
Cross Talk Between Macrophages and Cancer Cells in the Bone Metastatic Environment
Batoon, L., & McCauley, L. K. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.763846 · Cited by 22
Shakartalla, S. B., Ashmawy, N. S., Semreen, M. H., Fayed, B. E., Shareef, Z. A., Jayakumar, M. N., Ibrahim, S. M., Rahmani, M., Hamdy, R., & Soliman, S. S. M. (2024) · Scientific Reports · doi:10.1038/s41598-023-50866-y · Cited by 22
Pu, Y., Wang, L., Wu, H., Feng, Z., Wang, Y., & Guo, C. (2014) · Oncology Reports · doi:10.3892/or.2014.3124 · Cited by 22
Cifuentes, F., VALENZUELA, R. H., Contreras, H. R., & Castellón, E. A. (2015) · Oncology Letters · doi:10.3892/ol.2015.3522 · Cited by 22
Estrogen Receptor Status Predicts Late-Onset Skeletal Recurrence in Breast Cancer Patients
Han, H. H., Lee, S. H., Kim, B. G., Lee, J. H., Kang, S., & Cho, N. H. (2016) · Medicine · doi:10.1097/md.0000000000002909 · Cited by 22
Fu, A., Peh, Y. M., Ngan, W., Wei, N., & Luo, K. Q. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26816 · Cited by 22
Sonic hedgehog pathway mediates genistein inhibition of renal cancer stem cells
Li, E., Zhang, T., Sun, X., Li, Y., Geng, H., Yu, D., & Zhong, C. (2019) · Oncology Letters · doi:10.3892/ol.2019.10657 · Cited by 22
Miligy, I. M., Toss, M. S., Gorringe, K. L., Ellis, I. O., Green, A. R., & Rakha, E. A. (2022) · Pathobiology · doi:10.1159/000522244 · Cited by 21
Ren, S., Li, J., Dorado, J., Sierra, A., González‐Díaz, H., Duardo-Sánchez, A., & Shen, B. (2023) · Health Information Science and Systems · doi:10.1007/s13755-023-00264-5 · Cited by 22
Zullo, L., Filippiadis, D. K., Hendriks, L. E. L., Portik, D., Spicer, J. D., Wistuba, I. I., & Besse, B. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00642-1 · Cited by 23
Potential of Protein-based Anti-metastatic Therapy with Serpins and Inter α-Trypsin Inhibitors
Weidle, U. H., Birzele, F., & Tiefenthaler, G. (2018) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20081 · Cited by 21
Lung fibrosis is a novel therapeutic target to suppress lung metastasis of osteosarcoma
Yui, Y., Kumai, J., Watanabe, K., Wakamatsu, T., & Sasagawa, S. (2022) · International Journal of Cancer · doi:10.1002/ijc.34008 · Cited by 23
Liu, R., Su, S., Xing, J., Liu, K., Zhao, Y., Stangis, M. M., Jacho, D., Yildirim-Ayan, E. D., Gatto-Weis, C. M., Chen, B., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02849-0 · Cited by 25
Microfluidics and Nanomaterial-based Technologies for Circulating Tumor Cell Isolation and Detection
Cheng, S.-J., Hsieh, K. Y., Chen, S.-L., Chen, C., Huang, C., Tsou, H.-I., Kumar, P. V., Hsieh, C., & Chen, G. (2020) · Sensors · doi:10.3390/s20071875 · Cited by 19
Wang, L., Qiu, P., Xie, Y., Yin, N., Xu, J., Chen, A., Yi, J., Shi, W., Tang, J., & Xiang, J. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05385-5 · Cited by 20
Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy
Cao, J., Zhang, Z., Zhou, L., Luo, M., Li, L., Li, B., Nice, E. C., He, W., Zheng, S., & Huang, C. (2023) · MedComm · doi:10.1002/mco2.427 · Cited by 19
Mondal, J., Zhang, J., Qing, F., Li, S., Kumar, D., Huse, J. T., & Giancotti, F. G. (2025) · Nature Communications · doi:10.1038/s41467-025-56347-2 · Cited by 20
Self-citationLi, X., Zhu, G., Li, Y., Huang, H., Wu, D., 曹佩军, Shi, R., Chen, C., Su, L., Zhang, R., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1096818 · Cited by 18
The updates on metastatic mechanism and treatment of colorectal cancer
Ni, Y., Liang, Y., Li, M., Lin, Y., Zou, X., 韩芳毅, Cao, J., & Li, L. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154837 · Cited by 20
Zhang, Y., & Li, Y. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03277-6 · Cited by 19
Bense, R. D., Qiu, S.-Q., de Vries, E. G. E., Schröder, C. P., & Fehrmann, R. S. N. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.07.015 · Cited by 19
Inflammation awakens dormant cancer cells by modulating the epithelial–mesenchymal phenotypic state
Zhang, J., Zhang, J., Han, L., Wu, S., Li, J., Eaton, E. N., Yuan, B., Reinhardt, F., Li, H., Strasser, P. C., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2515009122 · Cited by 18
Reprogramming the tumor metastasis cascade by targeting galectin-driven networks
Perrotta, R. M., Bach, C. A., Salatino, M., & Rabinovich, G. A. (2021) · Biochemical Journal · doi:10.1042/bcj20200167 · Cited by 18
Kurgyis, Z., Kemény, L., Buknicz, T., Groma, G., Oláh, J., Jakab, Á., Polyánka, H., Zänker, K. S., Dittmar, T., Kemény, L., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060980 · Cited by 18
A circulating tumor cell cluster-based model for tumor metastasis (Hypothesis)
Hong, Y., Li, Z., & Zhang, Q. (2016) · Oncology Letters · doi:10.3892/ol.2016.5358 · Cited by 18
Metadata
- Authors
- Giancotti, F. G.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Giancotti, Filippo G.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 155
- Issue
- 4
- Pages
- 750-764
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC4354734
- OpenAlex
- W2088035579
- Cited by
- 586
- References
- 143
- Citations by year
- 2026: 20 · 2025: 35 · 2024: 45 · 2023: 68 · 2022: 47 · 2021: 50 · 2020: 53 · 2019: 47 · 2018: 53 · 2017: 39 · 2016: 57 · 2015: 44 · 2014: 28
- FWCI
- 4.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA175712)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- metastatic dormancy, cancer stem cells, metastasis-initiating cells, Wnt signaling, Notch signaling, BMP signaling, metastatic relapse, therapeutic interventions
- MeSH terms
- Animals, Extracellular Matrix, Humans, Neoplasm Metastasis, Neoplasms, Neoplastic Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review